[1] Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells. 2007; 25(11):2896-2902.[2] Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003;116(Pt 9): 1827-1835. [3] Jahr H, Bretzel RG. Insulin-positive cells in vitro generated from rat bone marrow stromal cells. Transplant Proc. 2003; 35(6):2140-2141.[4] Oh SH, Muzzonigro TM, Bae SH, et al. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest. 2004;84(5):607-617.[5] Tang DQ, Cao LZ, Burkhardt BR, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes. 2004;53(7):1721-1732. [6] Najafi R, Sharifi AM. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert Opin Biol Ther. 2013; 13(7):959-972. [7] Chhabra P, Brayman KL. Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med. 2013; 2(5):328-336.[8] Tsai PJ, Wang HS, Lin CH, et al. Intraportal injection of insulin-producing cells generated from human bone marrow mesenchymal stem cells decreases blood glucose level in diabetic rats. Endocr Res. 2013. [9] Hao H, Liu J, Shen J, et al. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. Biochem Biophys Res Commun. 2013. [10] 中国知网.中国学术期刊总库[DB/OL].2013-6-10. https://www.cnki.net[11] 肖红珍,张慧芹,刘阁玲.外源性骨髓间充质干细胞在糖尿病模型大鼠体内向胰腺迁移并分化为胰岛细胞的趋势[J].中国组织工程研究与临床康复,2007,11(15):2870-2873.[12] 刘弘光,夏鲲,刘晓玉,等.移植骨髓间充质干细胞治疗大鼠糖尿病的研究[J].中国组织化学与细胞化学杂志,2007,16(1):104-109.[13] 孟凡彪.大鼠骨髓间充质干细胞促进胰岛细胞再生的研究[D].辽宁:中国医科大学,2010:1-46.[14] 高斌,宓真,杜馨丽,等.同种异体骨髓间充质干细胞移植治疗糖尿病大鼠的实验研究[J].中国医药导报,2011,8(14):32-33.[15] 高赟,张祥迅,史瑾瑜,等.大鼠骨髓间充质干细胞同种异体移植治疗糖尿病的初步研究[J].中国糖尿病杂志,2009,17(7): 510-515.[16] 董庆玉.骨髓间充质干细胞移植对糖尿病大鼠治疗作用的实验研究[D].山东:山东大学,2008:1-86.[17] 田烁.大鼠骨髓间充质干细胞与胰岛细胞共培养及对糖尿病大鼠的治疗[D].河北:河北医科大学,2009:1-70.[18] 叶永峰.胰岛-骨髓间充质干细胞联合移植治疗大鼠Ⅰ型糖尿病的研究[D].上海:第二军医大学,2008:1-56.[19] 贾辰乐,商中华,张孝良,等.大鼠胰岛细胞和骨髓间充质干细胞联合移植治疗糖尿病小鼠的研究[J].中国现代医生,2010,48(3): 5-6.[20] David C Thomas T, Wong FS, Zaccone P, et al. Protection of islet grafts through TGF beta induced tolerogenic DC. Diabetes. 2013.[21] Tariq M, Masoud MS, Mehmood A, et al. Stromal cell derived factor-1alpha protects stem cell derived insulin-producing cells from glucotoxicity under high glucose conditions in-vitro and ameliorates drug induced diabetes in rats. J Transl Med. 2013;11:115.[22] Takemitsu H, Zhao D, Ishikawa S, et al. Mechanism of insulin production in canine bone marrow derived mesenchymal stem cells. Gen Comp Endocrinol. 2013;189:1-6.[23] Bhansali A, Walia R, Bhansali S, et al. Efficacy and Safety of Autologous Bone Marrow Derived Stem Cell Transplantation in patients with Type 2 Diabetes mellitus: A randomized placebo-controlled study. Cell Transplant. 2013.[24] Gabr MM, Zakaria MM, Refaie AF, et al. Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice. Cell Transplant. 2013;22(1):133-145.[25] Schmid RA, Stammberger U, Hillinger S, et al. Fas ligand gene transfer combined with low dose cyclosporine A reduces acute lung allograft rejection. Transpl Int. 2000;13 Suppl 1: S324-328.[26] Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75(3): 389-397.[27] Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99(10):3838-3843.[28] Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57(1): 11-20.[29] Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003; 31(10):890-896.[30] 肖承佐,章乐虹.骨髓间充质干细胞在1型糖尿病治疗中的应用[J].现代临床医学生物工程学杂志,2005,11(6):480-483.[31] 贾书辉,李彩萍.骨髓间充质干细胞在1型糖尿病中的应用[J].医学综述,2010,16(18):2800-2803.[32] Liu L, DiGirolamo CM, Navarro PA, et al. Telomerase deficiency impairs differentiation of mesenchymal stem cells. Exp Cell Res. 2004;294(1):1-8.[33] 崔红强,吴绍华.骨髓间充质干细胞研究进展[J].西南军医, 2009, 11(4): 715-717. |